Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial

Peer Review reports

Original Submission
28 Jun 2022	Submitted	Original manuscript
30 Jul 2022	Reviewed	Reviewer Report - Amr Arafat
30 Aug 2022	Reviewed	Reviewer Report - Kumar Gaurav
23 Sep 2022	Author responded	Author comments - Tienan Zhou
Resubmission - Version 2
23 Sep 2022	Submitted	Manuscript version 2
29 Nov 2022	Reviewed	Reviewer Report - Amr Arafat
8 Feb 2023	Reviewed	Reviewer Report - Kirsty Loudon
9 Mar 2023	Author responded	Author comments - Tienan Zhou
Resubmission - Version 3
9 Mar 2023	Submitted	Manuscript version 3
Publishing
10 Mar 2023	Editorially accepted
21 Mar 2023	Article published	10.1186/s13063-023-07236-w

Back to article page